Navigation Links
JAMA article contends earlier study overstated validity of findings on bisphenol A
Date:2/18/2009

In a letter to be published in this week's Journal of the American Medical Association (JAMA), Dr. S. Stanley Young, Assistant Director of Bioinformatics at the National Institute of Statistical Sciences, and Ming Yu, University of British Columbia, highlight the statistical limitations of a study claiming that bisphenol A is associated with cardiovascular diagnoses, diabetes and abnormal blood level liver enzyme levels. The earlier study, published in JAMA (September 16, 2008) by Dr. Ian A. Lang and colleagues, did not adequately address the potential for multiple testing to result in a false positive result.

Young and Yu note that the CDC National Health and Nutrition Examination Survey [2003-2004] that was used in Lang et al's study measured 275 environmental chemicals and a wide range of health outcomes.

Although the Lang et al study focused on one chemical and 16 health outcomes, Young and Yu note that it is important to focus on how many questions were at issue. They point out that with 32 possible health outcomes, including combinations, potentially associated with any of the 275 chemicals, along with multiple confounders and statistical models, there could be as many as approximately 9 million statistical models available to analyze the data. Given the number of questions at issue and possible modeling variations in the CDC design, Young and Yu conclude that the findings reported by the authors could well be the result of chance rather than representing real health concerns.


'/>"/>

Contact: Jamie Nunnelly
nunnelly@niss.org
919-685-9319
National Institute of Statistical Sciences
Source:Eurekalert

Page: 1

Related medicine news :

1. Nanoparticle smart bomb targets drug delivery to cancer cells
2. JAMA Article Provides Guidance to Physicians on End-of-Life Care
3. LegalView Updates Avandia Information Portal With New Articles Detailing Potentially Dangerous Side Effects
4. PEGASYS(R) Proven Effective as Hepatitis C Treatment for Latino Patients, According to Article in The New England Journal of Medicine
5. Team Designs Gold Nanoparticles to Deliver Multiple Drugs
6. Gold nanoparticles for controlled drug delivery
7. Fresh Thinking: Harvard Business Review Article Explores When and How Companies Must Reinvent Their Businesses
8. Nontoxic nanoparticle can deliver and track drugs
9. Nanoparticles trigger cell death?
10. Nationally Recognized Diabetes Specialist Dr. Steven Edelman to Provide Educational Articles on Diabetes to MyCareTeam's Website Community
11. Free Article Now Available: 'Rights Expanding for Plaintiffs with In Utero Injuries'
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... ... , media relations, content marketing, social media management, corporate communications, SEO and cause ... the state and in nearby New Hampshire, Massachusetts and Canada, Rosica will focus ...
(Date:2/23/2017)... Colorado (PRWEB) , ... February 23, 2017 , ... ... Magazine, an exciting, new, interactive publication where generations converge and explore the world ... expand their worldview, Dialog Magazine enables readers to gain understanding, increase empathy, and ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... new partnership with the Rhode Island Consortium for Autism Research and Treatment (RI-CART) ... for children with autism spectrum disorder (ASD) to see films in an environment ...
(Date:2/23/2017)... ... 2017 , ... Curemark, LLC announced today that the Blüm Study, a Phase ... 3-8 with Autism, is now enrolling at three new sites. These new sites are ... , “There are currently no approved drugs that address the core symptoms of ...
(Date:2/22/2017)... York (PRWEB) , ... February 22, 2017 , ... ... entrance and lobby of a new healthcare contact center in Georgia, PENETRON Specialty ... One of the nation’s largest healthcare systems recently invested $51 million to purchase ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... , Feb. 23, 2017  Cogentix Medical, Inc. ... and markets innovative proprietary products for the urology market, ... fiscal year ended December 31, 2016 before the market ... The Company will host a conference call and webcast ... Thursday, March 9, 2017 at 11:00 a.m. Eastern Time ...
(Date:2/23/2017)... Feb 23, 2017 Research and Markets has announced ... 2016" report to their offering. ... The latest research Menopause Drugs Price Analysis and Strategies - ... The research answers the following questions: ... How are they positioned in the Global Menopause market? ...
(Date:2/23/2017)... 23, 2017 Research and Markets has announced ... - 2016" report to their offering. ... The latest research Fibromyalgia Drugs Price ... in the global Fibromyalgia market. The research answers the ... marketed for Fibromyalgia and their clinical attributes? How are they positioned ...
Breaking Medicine Technology: